Allient (ALNT) Competitors $53.21 +1.44 (+2.78%) Closing price 04:00 PM EasternExtended Trading$53.85 +0.64 (+1.21%) As of 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALNT vs. TXG, EYPT, AEHR, TRNS, LAB, CTKB, SENS, QSI, FEIM, and MASSShould you be buying Allient stock or one of its competitors? The main competitors of Allient include 10x Genomics (TXG), Eyepoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Transcat (TRNS), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Frequency Electronics (FEIM), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Allient vs. Its Competitors 10x Genomics Eyepoint Pharmaceuticals Aehr Test Systems Transcat Standard BioTools Cytek Biosciences Senseonics Quantum-Si Frequency Electronics 908 Devices Allient (NASDAQ:ALNT) and 10x Genomics (NASDAQ:TXG) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Is ALNT or TXG more profitable? Allient has a net margin of 2.75% compared to 10x Genomics' net margin of -13.13%. Allient's return on equity of 9.97% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Allient2.75% 9.97% 4.67% 10x Genomics -13.13%-12.88%-10.03% Which has more risk & volatility, ALNT or TXG? Allient has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 2.05, suggesting that its share price is 105% more volatile than the S&P 500. Do institutionals and insiders believe in ALNT or TXG? 61.6% of Allient shares are held by institutional investors. Comparatively, 84.7% of 10x Genomics shares are held by institutional investors. 14.9% of Allient shares are held by company insiders. Comparatively, 10.0% of 10x Genomics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher valuation & earnings, ALNT or TXG? Allient has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllient$519.60M1.74$13.17M$0.8661.8710x Genomics$610.78M2.42-$182.63M-$0.70-16.99 Do analysts prefer ALNT or TXG? Allient presently has a consensus price target of $35.00, indicating a potential downside of 34.22%. 10x Genomics has a consensus price target of $13.65, indicating a potential upside of 14.83%. Given 10x Genomics' stronger consensus rating and higher probable upside, analysts plainly believe 10x Genomics is more favorable than Allient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allient 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.0010x Genomics 2 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.38 Does the media favor ALNT or TXG? In the previous week, 10x Genomics had 6 more articles in the media than Allient. MarketBeat recorded 10 mentions for 10x Genomics and 4 mentions for Allient. 10x Genomics' average media sentiment score of 0.72 beat Allient's score of 0.48 indicating that 10x Genomics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allient 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 10x Genomics 2 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Summary10x Genomics beats Allient on 10 of the 17 factors compared between the two stocks. Get Allient News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALNT vs. The Competition Export to ExcelMetricAllientELEC IndustryComputer SectorNASDAQ ExchangeMarket Cap$901.75M$5.88B$32.70B$10.49BDividend Yield0.26%2.61%3.20%4.80%P/E Ratio61.8727.46490.4227.32Price / Sales1.742.731,830.12194.55Price / Cash15.9024.2537.7761.53Price / Book3.383.227.766.81Net Income$13.17M$177.19M$820.59M$276.59M7 Day Performance19.52%2.42%0.13%0.15%1 Month Performance14.06%4.07%7.09%8.17%1 Year Performance184.39%32.87%23,957.94%35.50% Allient Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALNTAllient2.8072 of 5 stars$53.21+2.8%$35.00-34.2%+181.4%$901.75M$519.60M61.872,525Gap UpHigh Trading VolumeTXG10x Genomics3.9736 of 5 stars$12.64-0.9%$13.65+8.0%-29.1%$1.59B$610.78M-18.061,240Analyst ForecastEYPTEyepoint Pharmaceuticals1.5832 of 5 stars$13.62-0.8%$26.86+97.2%+29.4%$946.37M$43.27M-5.08120Trending NewsAEHRAehr Test Systems1.6809 of 5 stars$31.65+2.0%N/A+74.3%$929.64M$58.97M-243.4490Gap UpTRNSTranscat3.5772 of 5 stars$70.82-2.0%$112.20+58.4%-43.7%$673.12M$278.42M49.521,245Positive NewsLABStandard BioTools2.4768 of 5 stars$1.32-1.5%$1.55+17.4%-30.7%$511.87M$174.43M-4.13620News CoverageCTKBCytek Biosciences2.3269 of 5 stars$4.02+1.3%$5.60+39.3%-24.6%$505.08M$200.45M-80.40500SENSSenseonics1.8798 of 5 stars$0.57+22.0%$1.54+172.1%+21.4%$460.30M$25.47M-4.3590High Trading VolumeQSIQuantum-Si2.4985 of 5 stars$1.81+5.2%$3.48+92.0%+165.4%$348.29M$3.06M-2.66150News CoverageOptions VolumeGap UpFEIMFrequency Electronics2.3788 of 5 stars$38.27+9.6%$43.00+12.4%+197.5%$340.35M$69.81M16.71200Gap UpMASS908 Devices1.8887 of 5 stars$8.76-3.4%$8.00-8.7%+136.0%$325.26M$59.63M-16.2260 Related Companies and Tools Related Companies 10x Genomics Alternatives Eyepoint Pharmaceuticals Alternatives Aehr Test Systems Alternatives Transcat Alternatives Standard BioTools Alternatives Cytek Biosciences Alternatives Senseonics Alternatives Quantum-Si Alternatives Frequency Electronics Alternatives 908 Devices Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALNT) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allient Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allient With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
